Clinical Trial Update: Sildenafil in Heart Failure With Reactive Pulmonary Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial of sildenafil in heart failure with reactive pulmonary hypertension was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Maya Guglin | Conditions: Heart Failure With Reactive Pulmonary Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2019-03-13